Success Stories: Toward a World Beyond Resistance: NIW Approval for Antimicrobial Research Expert
Client’s Testimonial:
“My experience with NAILG was truly outstanding. As an Assistant Professor and researcher in biomedical sciences, I greatly valued their professionalism and attention to detail throughout my EB-2 NIW petition process. The team provided timely responses to every query, and their secure client portal made document uploads and form navigation remarkably easy. I was also impressed by how well they stayed current with evolving USCIS policies and clearly explained each step. What impressed me most was their experience and strategic guidance on how to effectively present my research credentials, especially in showcasing key publication merits, citation impact, and peer-reviewing contributions to strengthen the petition. Although they initially recommended filing under regular processing, they fully respected my decision to proceed with premium processing and efficiently adjusted the submission strategy. Overall, the entire process was smooth, transparent, and very well-organized, resulting in a successful outcome that I deeply appreciate.”
On September 18th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Assistant Professor in the Field of Biomedical Sciences (Approval Notice).
General Field: Biomedical Sciences
Position at the Time of Case Filing: Assistant Professor (Tenure-track)
Country of Origin: India
State of Residence at the Time of Filing: Alabama
Approval Notice Date: September 18th, 2025
Processing Time: 1 month, 14 days (Premium Processing Requested)
Case Summary:
Antimicrobial resistance (AMR) has become one of the most significant public health challenges of this century, threatening both human and animal health while straining the agricultural economy. Misuse of antibiotics in livestock, where sales of medically necessary drugs nearly double those for humans, has accelerated this crisis. The U.S. Department of Agriculture and national health agencies have identified AMR as a critical research priority requiring innovative solutions.
Innovating in Veterinary Pharmacology
A biomedical sciences researcher specializing in veterinary pharmacology has dedicated his career to tackling this issue through groundbreaking approaches. His work integrates nanoparticle-based drug delivery systems, studies on drug interactions and residues, and pharmacological education. These methods not only enhance the precision of treatments but also minimize harmful residues in the food chain, thereby safeguarding consumers and promoting agricultural sustainability. His findings directly support the U.S. strategy to improve antibiotic stewardship and ensure safer healthcare outcomes.
A Record of Impact
The strength of his case was underscored by notable achievements: 26 peer-reviewed journal articles (9 first-authored), one book chapter, and 194 citations to his published work. One of his articles ranked in the top 10% most-cited papers in Pharmacology & Toxicology for its year of publication. He has also performed at least 20 peer reviews for leading journals, confirming his recognition as an expert in his field. His work has been supported by funding from the U.S. Department of Agriculture (USDA), further reflecting its national significance. Invitations to present at major conferences highlighted his standing among peers.
Approval and Next Steps
With NAILG’s representation, this petition persuasively demonstrated how his research addresses an urgent national need. USCIS approved the case, recognizing both the originality of his contributions and their importance to public health and food safety in the United States. This approval empowers him to continue advancing solutions that slow the spread of antimicrobial resistance, protect consumers, and ensure resilient healthcare and agricultural systems for the future.